CME Group Stock Price, News & Analysis (NASDAQ:CME)

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CME shares.
View CME analyst ratings or view top-rated stocks.

10 Wall Street research analysts have issued 12-month price targets for CME Group's shares. Their CME share price targets range from $180.00 to $250.00. On average, they expect the company's share price to reach $220.00 in the next twelve months. This suggests a possible upside of 0.8% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $168.16 at the beginning of the year. Since then, CME stock has increased by 29.8% and is now trading at $218.34.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our CME earnings forecast.

CME Group Inc. (NASDAQ:CME) issued its earnings results on Wednesday, October, 25th. The financial services provider reported $2.25 EPS for the quarter, beating the consensus estimate of $2.21 by $0.04. The financial services provider earned $1.34 billion during the quarter, compared to analyst estimates of $1.34 billion. CME Group had a net margin of 57.03% and a trailing twelve-month return on equity of 11.70%.
Read the conference call transcript.

CME Group announced a quarterly dividend on Thursday, November 9th. Stockholders of record on Friday, December 8th will be given a dividend of $1.10 per share on Thursday, December 28th. This represents a $4.40 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date is Thursday, December 7th.
Read our dividend analysis for CME.

CME Group (NASDAQ:CME) pays an annual dividend of $4.40 per share and currently has a dividend yield of 2.00%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 52.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 46.76% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Horizon Kinetics Blockchain Development ETF (BCDF), Tema Monopolies and Oligopolies ETF (TOLL), SmartETFs Dividend Builder ETF (DIVS), TrueShares Low Volatility Equity Income ETF (DIVZ), Capital Link Global Fintech Leaders ETF (KOIN), VanEck Morningstar ESG Moat ETF (MOTE) and Amplify Transformational Data Sharing ETF (BLOK).

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (1.97%), Parnassus Investments LLC (1.57%), Morgan Stanley (1.35%), FMR LLC (1.12%), Fiera Capital Corp (1.07%) and Northern Trust Corp (1.02%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.